UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004731
Receipt No. R000005632
Scientific Title Phase II study of carboplatin and pemetrexed plus bevacizumab after failure of first-line EGFR TKI therapy for non-small-cell lung cancer harboring EGFR mutation.
Date of disclosure of the study information 2010/12/15
Last modified on 2018/12/21 10:21:21

No. Disposal Last modified on Item of update
1 Insert 2010/12/15 17:20:53
2 Update 2012/08/26 18:47:06 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2012/12/17 18:42:54 Key exclusion criteria
Key exclusion criteria
4 Update 2014/06/17 16:23:10 TEL
Email
Address
Address
5 Update 2015/06/15 15:25:04 Recruitment status
6 Update 2016/06/15 14:32:57 Name of primary sponsor
Organization
7 Update 2018/12/21 10:21:21 Recruitment status
Anticipated trial start date
Publication of results


Contact us.